Recent Company News

• 02:37 AM ET May 23, 2025
  

  Medipal Holdings president and CEO Shuichi Watanabe is undergoing medical treatment (¥2264.5000, 0)

• 11:59 PM ET May 13, 2025
  

  StreetAccount Summary - Trading higher/lower: Asia mid-morning

• 10:44 PM ET May 13, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 02:52 AM ET May 13, 2025
  

  Medipal Holdings reports FY net income attributable ¥40.28B vs guidance ¥33.50B and FactSet ¥44.39B [3 est, ¥39.82-47.35B] (¥2478.5000, 0)

• 02:44 AM ET May 07, 2025
  

  JCR Pharmaceuticals receives FDA's orphan drug destination for JR-446 for mucopolysaccharidosis type IIIB (¥483.0000, 0)

• 02:46 AM ET Apr 30, 2025
  

  Medipal Holdings increases forecast for year-end dividend to JPY32/sh vs prior guidance JPY30/sh (¥2427.5000, 0)

• 11:42 PM ET Apr 08, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (275 total)

• 11:28 PM ET Apr 06, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (102 total)

• 01:43 AM ET Feb 10, 2025
  

  Medipal Holdings reports 9M net income attributable ¥56.71B, +13% vs year-ago ¥50.24B (¥2232.0000, 0)

• 06:25 PM ET Dec 05, 2024
  

  Medipal Holdings to acquire 20% stake in Teva Takeda Pharma (¥2405.5000, 0)